Try it
Microbiology · Bacteriology: Burkholderia pseudomallei
Sample itemA 52-year-old diabetic rice farmer from coastal Karnataka presents in the monsoon with fever, pneumonia and multiple liver and subcutaneous abscesses. Culture shows oxidase-positive, bipolar-staining Gram-negative bacilli forming wrinkled colonies. Which therapy is appropriate for the initial intensive phase?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Intravenous ceftazidime or meropenem
Melioidosis, caused by Burkholderia pseudomallei from soil and water, occurs in diabetics and other hosts during the rainy season in endemic coastal regions. The intensive phase uses intravenous ceftazidime or meropenem for at least 10 to 14 days, followed by eradication therapy with cotrimoxazole for several months to prevent relapse. The organism is intrinsically resistant to aminoglycosides and many other drugs.
Option by option
A. Intravenous ceftazidime or meropenem (correct)
Correct. Ceftazidime or a carbapenem is the intensive-phase backbone.
B. Intravenous gentamicin alone
Aminoglycosides are intrinsically ineffective against B. pseudomallei.
C. Oral amoxicillin for 5 days
Oral amoxicillin for 5 days is inadequate; the organism is resistant to it and this is a severe disseminated infection.
D. Oral doxycycline alone
Doxycycline alone is not adequate for severe disease; it is only a possible alternative in the long eradication phase.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Microbiology questions
- BacteriologyA patient has profuse painless watery 'rice-water' stools and rapid dehydration. The cau…
- Culture mediaThayer–Martin medium is used selectively to isolate which organism?
- Immunology and serologyWhich of the following is a non-treponemal test for syphilis?
- BacteriologyAlbert's stain is used to demonstrate which of the following?